A missing link between RON expression and oncological outcomes in resected left-sided pancreatic cancer

作者: Dai Hoon Han , Chang Moo Kang , Sung Whan Lee , Ho Kyoung Hwang , Woo Jung Lee

DOI: 10.3892/OL.2017.6696

关键词:

摘要: Alteration and activation of recepteur d'origine nantais (RON) expression is known to be associated with cancer progression decreased survival in various types human cancer, including pancreatic cancer. Therefore, the present study, RON levels were determined resected left-sided evaluate potential oncological role clinical setting distal From January 2005 December 2011, a total 57 patients underwent radical pancreatectomy for Ductal adenocarcinoma was confirmed all patients. Among these patients, 17 who received preoperative neoadjuvant treatment 7 without available paraffin-embedded tissue blocks excluded from study. cell lines ASPC-1, BxPC-3, MiaPaCa-3 Panc-1, as well specimens by Western blot analysis. vascular endothelial growth factor (VEGF) overexpression also evaluated immunohistochemistry using pre-diluted anti-RON anti-VEGF antibodies. An association identified between outcome overexpression. Increased observed two lines, AsPC-1 BxPC-3. detected 15/33 (45.5%) immunohistochemistry. No significant VEGF (25.5 vs. 87.9%; P=0.667). differences disease-free or disease-specific identified. Although results previous studies have suggested that target study no any adverse effect

参考文章(37)
E. Ramsay Camp, Anthony Yang, Mike J. Gray, Fan Fan, Stanley R. Hamilton, Douglas B. Evans, Andrea T. Hooper, Daniel S. Pereira, Daniel J. Hicklin, Lee M. Ellis, Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. Cancer. ,vol. 109, pp. 1030- 1039 ,(2007) , 10.1002/CNCR.22490
J Chakedis, R French, M Babicky, D Jaquish, H Howard, E Mose, R Lam, P Holman, J Miyamoto, Z Walterscheid, A M Lowy, A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. Oncogene. ,vol. 35, pp. 3249- 3259 ,(2016) , 10.1038/ONC.2015.384
C Collesi, M M Santoro, G Gaudino, P M Comoglio, A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Molecular and Cellular Biology. ,vol. 16, pp. 5518- 5526 ,(1996) , 10.1128/MCB.16.10.5518
Sunny Guin, Hang-Ping Yao, Ming-Hai Wang, RON Receptor Tyrosine Kinase as a Target for Delivery of Chemodrugs by Antibody Directed Pathway for Cancer Cell Cytotoxicity Molecular Pharmaceutics. ,vol. 7, pp. 386- 397 ,(2010) , 10.1021/MP900168V
H-L Cheng, H-S Liu, Y-J Lin, H H-W Chen, P-Y Hsu, T-Y Chang, C-L Ho, T-S Tzai, N-H Chow, Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder British Journal of Cancer. ,vol. 92, pp. 1906- 1914 ,(2005) , 10.1038/SJ.BJC.6602593
M. Park, M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, G. Vande Woude, Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 6379- 6383 ,(1987) , 10.1073/PNAS.84.18.6379
Gabriella Ferrandina, Enrica Martinelli, Marco Petrillo, Maria Grazia Prisco, Adriana Zucconi, Salvatore Santaguida, Gianfranco Zannoni, Giovanni Scambia, Cristiano Ferlini, Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients. Gynecologic Oncology. ,vol. 111, pp. 237- 243 ,(2008) , 10.1016/J.YGYNO.2008.07.013
Wen-Ying Lee, Helen H.W. Chen, Nan-Haw Chow, Wu-Chou Su, Pin-Wen Lin, How-Ran Guo, Prognostic Significance of Co-expression of RON and MET Receptors in Node-Negative Breast Cancer Patients Clinical Cancer Research. ,vol. 11, pp. 2222- 2228 ,(2005) , 10.1158/1078-0432.CCR-04-1761
Raghu Kalluri, EMT: when epithelial cells decide to become mesenchymal-like cells. Journal of Clinical Investigation. ,vol. 119, pp. 1417- 1419 ,(2009) , 10.1172/JCI39675